Please login to the form below

Not currently logged in
Email:
Password:

EUSA Pharma

This page shows the latest EUSA Pharma news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on kidney cancer drug

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on kidney cancer drug

Read more. Celgene’s Beck joins Orchard Therapeutics board. Promising UK cell and gene therapy company Orchard Therapeutics has bolstered its board with an experienced pharma drug development and supply chain ... EUSA’s Fotivda approved for NHS use

Latest news

  • NICE backs EUSA's RCC treatment Fotivda NICE backs EUSA's RCC treatment Fotivda

    EUSA Pharma has won NICE backing for Fotivda (tivozanib) as a first-line treatment for advanced renal cell carcimona (RCC). ... Lee Morley, chief executive officer for EUSA Pharma, said: “We are very pleased that NICE are recommending the use of

  • EUSA receives European green light for kidney cancer treatment Fotivda EUSA receives European green light for kidney cancer treatment Fotivda

    The European Commission (EC) has approved EUSA Pharma’s vascular endothelial growth factor receptor (VEGFR) inhibitor Fotivda (tivozaniv) as a first-line treatment for adults with advanced renal cell carcinoma (RCC). ... EUSA Pharma, which was formed

  • Samsung Bioepis wins CHMP nod for second Humira biosimilar Samsung Bioepis wins CHMP nod for second Humira biosimilar

    Novartis' CDK4/6 inhibitor Kisqali (ribociclib) got the nod for the treatment of locally advanced or metastatic breast cancer - three months after getting FDA approval in breast cancer - while Eusa Pharma ... Tivozanib - originally developed by Aveo

  • Havas Lynx excels at PM Society Awards Havas Lynx excels at PM Society Awards

    Craft Award for Direct Mail - Sudler London for Pfizer. Craft Award for Sales Aid - Frontera London for EUSA Pharma . ... Primary Care Campaign - Havas Lynx for ViiV Healthcare. Secondary Care Campaign - Frontera London for EUSA Pharma.

  • Shire drawn into Luxembourg tax haven exposé Shire drawn into Luxembourg tax haven exposé

    Investigations into Luxembourg's tax activities certainly stretch back several years, and this is not the first time that a pharma company has been implicated in the practice. ... Other pharma companies appearing in an ICIJ database of leaked documents -

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Pharma deals in March 2015 Pharma deals in March 2015

    The other deal of interest is the re-emergence of EUSA Pharma with products acquired from Jazz Pharmaceuticals. ... investor, Essex Woodlands, has bought back products worth $27m and the EUSA Pharma name from Jazz for an undisclosed amount.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Neurocentrx appoints two members to the board. Nigel Brooksby and Dr Tim Corn join the pharma group. ... Joining Brooksby is EUSA Pharma’s former chief medical officer Dr Tim Corn, who becomes the pharma group’s non-executive director.

  • EUSA Pharma appoints Rolf Hoffmann to its board EUSA Pharma appoints Rolf Hoffmann to its board

    EUSA Pharma appoints Rolf Hoffmann to its board. He most recently worked at Amgen for over a decade. ... Oncology-focused pharmaceutical group EUSA Pharma has added to its board of directors in the form of Rolf Hoffman.

  • EUSA Pharma adds William Crouse to board of directors EUSA Pharma adds William Crouse to board of directors

    EUSA Pharma adds William Crouse to board of directors. Comes as firm hopes to become global leader in biotechnology. ... Bryan Morton, executive chairman at EUSA Pharma, said: “ We have great ambitions for EUSA, and plan to grow our existing profitable

  • EUSA Pharma appoints Lee Morley as its new chief executive EUSA Pharma appoints Lee Morley as its new chief executive

    EUSA Pharma appoints Lee Morley as its new chief executive. UK specialty pharmaceutical company also adds Göran Ando to its board. ... EUSA Pharma has appointed Lee Morley to be its new chief executive officer, taking over from Bryan Morton who becomes

  • EUSA Pharma founder to chair Glide Pharma EUSA Pharma founder to chair Glide Pharma

    EUSA Pharma founder to chair Glide Pharma. Bryan Morton replaces Mark Kirby. ... Morton was most recently chief executive at oncology specialist EUSA Pharma – a company he also founded.

More from appointments
Approximately 3 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Big wins for Frontera at the 2016 PM Awards

    Two golds:. Caphosol secondary care campaign and the associated sales aid, developed for EUSA Pharma. ... Two silvers:. Caphosol advertisement campaign for EUSA Pharma and Galderma My Skin Journal app for Galderma UK.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Quintiles Medical Communications

Quintiles’ award-winning medical communications group sits at the heart of the enterprise. We offer a range of innovative strategic services,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics